Recent Publications on Pancreatic Neoplasms: |  |
Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine.
PURPOSE: The epidermal growth factor receptor ErbB-1 is commonly expressed...
Direct Link | 4th October, 2008
| Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilian-University,
|
Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas.
PURPOSE: An invasive growth pattern is one of the hallmarks of pancreatic...
Direct Link | 4th October, 2008
| Chemotherapy Division, Cancer Proteomics Project, National Cancer Center
|
| Diagnostic and prognostic biomarkers in pancreatic carcinoma.
| 3rd October, 2008
| Department of Pathology, Pennsylvania State University Hershey Medical
|
| Nutritional and pharmacologic support in patients with pancreatic cancer.
| 1st October, 2008
| Gastroenterology Department, University Hospital Center Rijeka, Rijeka,
|
| [Use of tumor marker CA50]
| 30th September, 2008
|
|
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.
A National Cancer Institute summit meeting on gastroenteropancreatic...
Direct Link | 30th September, 2008
| Department of Gastroenterological Surgery, Yale University School of
|
| [Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine for locally advanced inoperable pancreatic cancer]
| 26th September, 2008
| Faculty of Medicine, Ben Gurion University, Beer Sheba.
|
Histologic, Immunohistochemical, and Molecular Classification of 52 IPMNs of the Pancreas.
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) of the...
Direct Link | 25th September, 2008
| *Department of Pathology, University of Utah School of Medicine daggerARUP
|
| Inguino-scrotal herniation of urinary bladder diverticulum in a patient with pancreatic carcinoma: a potential pitfall in whole-body 18F-FDG PET-CT.
| 24th September, 2008
| Department of Clinical Radiology, University of Muenster, Germany.
|
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.
PURPOSE: Evaluate the activity of everolimus (RAD001) in combination with...
Direct Link | 23rd September, 2008
| Department of Gastrointestinal Medical Oncology, Unit 426, The University
|
Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells.
During tumor cell invasion, certain extracellular matrix (ECM) components...
Direct Link | 19th September, 2008
| Laboratory of Immunodynamics, Department of Microbiology and Immunology,
|
Unusual serum electrophoresis pattern in a woman with pancreatic carcinoma.
The aim of our study was to assess whether the influence of nutritional...
Direct Link | 16th September, 2008
| Department of Clinical Chemistry, University Hospital Ghent, Ghent,
|
Cancer genetics. A detailed genetic portrait of the deadliest human cancers.
PURPOSE: Evaluate the activity of everolimus (RAD001) in combination with...
Direct Link | 10th September, 2008
|
|
| Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer.
| 10th September, 2008
| Second Department of Surgery, Wakayama Medical University, School of
|
| [Endoscopic ultrasonography in patients with suspected neuroendocrine tumors]
| 6th September, 2008
|
|
